Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Myers, Kasiani C  [Clear All Filters]
Journal Article
Wallace G, Jodele S, Howell J, Myers KC, Teusink A, Zhao X, Setchell K, Holtzapfel C, Lane A, Taggart C, et al. Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2015.
Joyce CE, Saadatpour A, Ruiz-Gutierrez M, Bolukbasi OVargel, Jiang L, Thomas DD, Young S, Hofmann I, Sieff C, Myers KC, et al. TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome. J Clin Invest. 2019;130.
Jodele S, Dandoy CE, Danziger-Isakov L, Myers KC, El-Bietar J, Nelson A, Wallace G, Teusink-Cross A, Davies SM. Terminal complement blockade after HSCT is safe without meningococcal vaccination. Biol Blood Marrow Transplant. 2016.
Morrison CF, Drake S, Basile NL, Horn MJane, Lambert J, Myers KC, Pai ALH. Symptoms of Survivors of Pediatric Hematopoietic Stem Cell Transplant by Age, Sex, and Transplant Type. J Pediatr Hematol Oncol Nurs. 2022;39(5):277-289.
Koo J, Auletta JJ, Hartley DM, Huber J, Jaglowski S, Kapadia M, Kusnier K, Lehmann L, Maakaron J, Myers KC, et al. Secondary impact of the COVID-19 pandemic on patients and the cell therapy healthcare ecosystem. Transplant Cell Ther. 2022.
Nelson AS, Marsh RA, Myers KC, Davies SM, Jodele S, O'Brien TA, Mehta PA. A reduced intensity conditioning regimen for patients with Dyskeratosis Congenita undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016.
Bender JD, Del Toro HOquendo-, Benoit J, Howell JC, Badia P, Davies SM, Grimley MS, Jodele S, Phillips C, Burns K, et al. Reduced Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplant: Gonadal Toxicity and Fertility Following Pediatric HSC. Transplant Cell Ther. 2022.
Khandelwal P, Emoto C, Fukuda T, Vinks AA, Neumeier L, Dandoy CE, El-Bietar J, Chandra S, Davies SM, Bleesing JJ, et al. A Prospective Study of Alemtuzumab as a Second Line Agent for Steroid Refractory Acute Graft Versus Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2016.
Sarkar N, Myers KC, Lane A, Davies SM, Benoit SW. Pre-transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients. Pediatr Blood Cancer. 2024:e30853.
Cizek SM, El-Bietar J, Rubinstein J, Dandoy C, Wallace GH, Nelson A, Khandelwal P, Myers KC, Hoefgen HR. Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2019.
Knight TE, Ahn KWoo, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, et al. No impact of CD34 cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Bone Marrow Transplant. 2023.
Snyder AJ, Campbell KM, Lane A, Mehta PA, Myers KC, Davies SM, Koo J. Liver abnormalities are frequent and persistent in patients with Fanconi anemia. Blood Adv. 2024.
Ruiz-Torres S, Brusadelli MG, Witte DP, Wikenheiser-Brokamp KA, Sauter S, Nelson AS, Sertorio M, Chlon TM, Lane A, Mehta PA, et al. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell. 2020.
Koo J, Ziady AG, Reynaud D, Abdullah S, Luebbering N, Kahn S, Langenberg L, Strecker L, Lake K, Dandoy CE, et al. Increased body mass index augments endothelial injury and clinical outcomes after hematopoietic stem cell transplant: Higher BMI increases endothelial injury after BMT. Transplant Cell Ther. 2023.
Wang YZM, Howell JC, Grimley MS, Lane A, Davies SM, Myers KC. Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Pediatr Transplant. 2021:e13983.
Himes RW, Chiou EH, Queliza K, Shouval DS, Somech R, Agarwal S, Jajoo K, Ziegler DS, Kratz CP, Huang J, et al. Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders. J Pediatr. 2020.
Swauger S, Sabulski A, Hornung L, Wasserman H, Myers KC, Howell JC. Bone Health Outcomes at One Year After HSCT in a Heterogeneous Pediatric Population. Transplant Cell Ther. 2021.